Our personalized treatment protocol targets the unique cancer characteristics and individual combination of genetic traits. This method of high precision aims to improve treatment efficacy.
In contrast to conventional chemotherapy which offers a one-size-fits-all approach, our forefront technology allows doctors to focus on matching the most accurate and effective treatment to each individual cancer patient based on the genetic profile of the cancer and the individual. Regardless of cancer stages and types, precision medicine identifies the genetic profiles every single cancer patient exhibits and tailor-make the therapeutic options to patients, thus improving treatment efficacy and reducing side effects to patients.
At the same time, we ensure timely access of drugs registered in the USA and Europe, including immunotherapy and targeted therapy, providing doctors with a wide range of therapeutic options. Taking lung cancer as an example, targeted therapies have made a meaningful difference for patients with EGFR mutation. Unlike conventional chemotherapy, targeted therapies limit their attack to cancer cells carrying the mutations – sparing normal cells and reducing toxic side effects, achieving better treatment outcomes.